Digital What AI really means for biology and the pharmaceutical indu... A blanket statement like ’We need to use AI’ today is just as futile as saying ’We need to use electricity’ during the second industrial revolution.
Oncology ASCO 2023 – Jaydev Thakkar In our penultimate video from ASCO 2023, editor-in-chief Jonah Comstock touches base with Biofourmis chief operating officer Jaydev Thakkar.
Digital Short-term crucial to future of AI drug discovery One of the lead prospects in a new generation of AI-developed drug candidates struggled in late-stage trials.
R&D New strategies to manage clinical trial risk It is essential for healthcare and pharmaceutical companies to be aware of both critical and non-critical risks when conducting quality clinical trials.
Sales & Marketing Delivering for the 5 in 10,000 patients with a rare disease An estimated 30 million people are living with a rare disease in the European Union alone.
Digital The digital skills pharma leaders need in 2023 Pharma companies are needing to look at cost-effective ways to stay ahead of the competition.
News Isomorphic Labs raises $5bn in massive third round In yet another sign of the appetite for AI companies among investors, Isomorphic Labs has raised a whopping $5bn in a Series C financing.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.